Diabetes, Vol 46, Issue 9 1481-1490, Copyright © 1997 by American Diabetes Association

ARTICLES

Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells

A Bierhaus, S Chevion, M Chevion, M Hofmann, P Quehenberger, T Illmer, T Luther, E Berentshtein, H Tritschler, M Muller, P Wahl, R Ziegler and PP Nawroth
Department of Internal Medicine, University of Heidelberg, Germany.

Depletion of cellular antioxidant defense mechanisms and the generation of oxygen free radicals by advanced glycation end products (AGEs) have been proposed to play a major role in the pathogenesis of diabetic vascular complications. Here we demonstrate that incubation of cultured bovine aortic endothelial cells (BAECs) with AGE albumin (500 nmol/l) resulted in the impairment of reduced glutathione (GSH) and ascorbic acid levels. As a consequence, increased cellular oxidative stress led to the activation of the transcription factor NF-kappaB and thus promoted the upregulation of various NF-kappaB-controlled genes, including endothelial tissue factor. Supplementation of the cellular antioxidative defense with the natural occurring antioxidant alpha-lipoic acid before AGE albumin induction completely prevented the AGE albumin-dependent depletion of reduced glutathione and ascorbic acid. Electrophoretic mobility shift assays (EMSAs) revealed that AGE albumin-mediated NF-kappaB activation was also reduced in a time- and dose-dependent manner as long as alpha-lipoic acid was added at least 30 min before AGE albumin stimulation. Inhibition was not due to physical interactions with protein DNA binding, since alpha-lipoic acid, directly included into the binding reaction, did not prevent binding activity of recombinant NF-kappaB. Western blots further demonstrated that alpha-lipoic acid inhibited the release and translocation of NF-kappaB from the cytoplasm into the nucleus. As a consequence, alpha-lipoic acid reduced AGE albumin-induced NF-kappaB mediated transcription and expression of endothelial genes relevant in diabetes, such as tissue factor and endothelin-1. Thus, supplementation of cellular antioxidative defense mechanisms by extracellularly administered alpha-lipoic acid reduces AGE albumin-induced endothelial dysfunction in vitro.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Artwohl, K. Muth, K. Kosulin, R. de Martin, T. Holzenbein, G. Rainer, A. Freudenthaler, N. Huttary, L. Schmetterer, W. K. Waldhausl, et al. R-(+)-{alpha}-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/E2F-1 Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E681 - E689. [Abstract] [Full Text] [PDF]

				M. Lappas, M. Permezel, and G. E Rice Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-{kappa}B and extracellular signal-regulated kinase 1/2 J. Endocrinol., May 1, 2007; 193(2): 269 - 277. [Abstract] [Full Text] [PDF]

				A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch Diabetes and Advanced Glycoxidation End Products. Diabetes Care, June 1, 2006; 29(6): 1420 - 1432. [Full Text] [PDF]

				S. Menini, L. Amadio, G. Oddi, C. Ricci, C. Pesce, F. Pugliese, M. Giorgio, E. Migliaccio, P. Pelicci, C. Iacobini, et al. Deletion of p66Shc Longevity Gene Protects Against Experimental Diabetic Glomerulopathy by Preventing Diabetes-Induced Oxidative Stress Diabetes, June 1, 2006; 55(6): 1642 - 1650. [Abstract] [Full Text] [PDF]

				A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]

				J. Steffel, T. F. Luscher, and F. C. Tanner Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications Circulation, February 7, 2006; 113(5): 722 - 731. [Abstract] [Full Text] [PDF]

				C. Iacobini, G. Oddi, S. Menini, L. Amadio, C. Ricci, C. Di Pippo, M. Sorcini, F. Pricci, F. Pugliese, and G. Pugliese Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice Am J Physiol Renal Physiol, September 1, 2005; 289(3): F611 - F621. [Abstract] [Full Text] [PDF]

				G. Basta, G. Lazzerini, S. Del Turco, G. M. Ratto, A. M. Schmidt, and R. De Caterina At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1401 - 1407. [Abstract] [Full Text] [PDF]

				R. A. Kowluru and S. Odenbach Effect of Long-Term Administration of {alpha}-Lipoic Acid on Retinal Capillary Cell Death and the Development of Retinopathy in Diabetic Rats Diabetes, December 1, 2004; 53(12): 3233 - 3238. [Abstract] [Full Text] [PDF]

				N. Marx, D. Walcher, N. Ivanova, K. Rautzenberg, A. Jung, R. Friedl, V. Hombach, R. de Caterina, G. Basta, M.-P. Wautier, et al. Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products Diabetes, October 1, 2004; 53(10): 2662 - 2668. [Abstract] [Full Text] [PDF]

				H. Konishi, M. Nakatsuka, C. Chekir, S. Noguchi, Y. Kamada, A. Sasaki, and Y. Hiramatsu Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts Hum. Reprod., September 1, 2004; 19(9): 2156 - 2162. [Abstract] [Full Text] [PDF]

				Y. Chen, S. S. Yan, J. Colgan, H.-P. Zhang, J. Luban, A. M. Schmidt, D. Stern, and K. C. Herold Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products J. Immunol., July 15, 2004; 173(2): 1399 - 1405. [Abstract] [Full Text] [PDF]

				D. Sumi and L. J. Ignarro Regulation of Inducible Nitric Oxide Synthase Expression in Advanced Glycation End Product-Stimulated RAW 264.7 Cells: The Role of Heme Oxygenase-1 and Endogenous Nitric Oxide Diabetes, July 1, 2004; 53(7): 1841 - 1850. [Abstract] [Full Text] [PDF]

				S. Schiekofer, M. Andrassy, J. Chen, G. Rudofsky, J. Schneider, T. Wendt, N. Stefan, P. Humpert, A. Fritsche, M. Stumvoll, et al. Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor {kappa}B in PBMCs Diabetes, March 1, 2003; 52(3): 621 - 633. [Abstract] [Full Text] [PDF]

				M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al. Activation of Tubular Epithelial Cells in Diabetic Nephropathy Diabetes, December 1, 2002; 51(12): 3532 - 3544. [Abstract] [Full Text] [PDF]

				J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]

				G. Romeo, W.-H. Liu, V. Asnaghi, T. S. Kern, and M. Lorenzi Activation of Nuclear Factor-{kappa}B Induced by Diabetes and High Glucose Regulates a Proapoptotic Program in Retinal Pericytes Diabetes, July 1, 2002; 51(7): 2241 - 2248. [Abstract] [Full Text] [PDF]

				L. Wu and B. H.J. Juurlink Increased Methylglyoxal and Oxidative Stress in Hypertensive Rat Vascular Smooth Muscle Cells Hypertension, March 1, 2002; 39(3): 809 - 814. [Abstract] [Full Text] [PDF]

				A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-{kappa}B Diabetes, December 1, 2001; 50(12): 2792 - 2808. [Abstract] [Full Text] [PDF]

				G. PUGLIESE, F. PRICCI, C. IACOBINI, G. LETO, L. AMADIO, P. BARSOTTI, L. FRIGERI, D. K. HSU, H. VLASSARA, F.-T. LIU, et al. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice FASEB J, November 1, 2001; 15(13): 2471 - 2479. [Abstract] [Full Text] [PDF]

				A. Kumar, K. S. Hawkins, M. A. Hannan, and M. B. Ganz Activation of PKC-beta I in glomerular mesangial cells is associated with specific NF-kappa B subunit translocation Am J Physiol Renal Physiol, October 1, 2001; 281(4): F613 - F619. [Abstract] [Full Text] [PDF]

				K Kiuchi, J Nejima, T Takano, M Ohta, H Hashimoto, and G F BAXTER Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients Heart, January 1, 2001; 85(1): 87 - 91. [Abstract] [Full Text]

				C. Kunsch and R. M. Medford Oxidative Stress as a Regulator of Gene Expression in the Vasculature Circ. Res., October 15, 1999; 85(8): 753 - 766. [Abstract] [Full Text] [PDF]

				S. Fischer, M. Clauss, M. Wiesnet, D. Renz, W. Schaper, and G. F. Karliczek Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO Am J Physiol Cell Physiol, April 1, 1999; 276(4): C812 - C820. [Abstract] [Full Text] [PDF]

				M. E. Eremeeva and D. J. Silverman Effects of the Antioxidant alpha -Lipoic Acid on Human Umbilical Vein Endothelial Cells Infected with Rickettsia rickettsii Infect. Immun., May 1, 1998; 66(5): 2290 - 2299. [Abstract] [Full Text] [PDF]